Retinal vein occlusion is a vascular condition in which a vein carrying blood away from the retina becomes blocked, leading to backed-up pressure, fluid leakage, and, in some cases, sudden vision changes. As one of the more common vision loss causes tied to blood vessel disease, it shares risk factors with other cardiovascular conditions and is generally treated as both an eye disease and a marker of broader vascular health.
What Are the Main RVO Types?
Retinal vein occlusion is generally classified by which vein is affected. Central retinal vein occlusion involves blockage of the main vein draining the entire retina and tends to produce more widespread and often more severe visual symptoms. Branch retinal vein occlusion involves a smaller tributary vein, affecting only the portion of the retina it drains, and typically produces more localized visual changes. Both types can occur with or without significant swelling of the macula, which strongly influences the visual impact and treatment approach in each case.
What Causes a Retinal Vein to Become Blocked?
The exact mechanism is not always identified in an individual patient, but retinal vein occlusion is strongly associated with underlying vascular risk factors, including high blood pressure, high cholesterol, diabetes, and glaucoma. Age is also a significant factor, with occlusion becoming more common in older adults. Because retinal veins and arteries often share a common structural sheath at points where they cross, hardened or thickened arteries, common with high blood pressure, can compress an adjacent vein and contribute to blockage. This overlap with common cardiovascular risk factors is why patients diagnosed with RVO are often referred for a broader medical evaluation, not just eye-focused care.
How Does Retinal Vein Occlusion Present?
Sudden, painless vision loss or blurring in one eye is the hallmark presentation of retinal vein occlusion, ranging from mild blurring to more significant visual impairment depending on the type and extent of occlusion and whether the macula is involved. Because sudden vision changes can also indicate other serious eye or neurological conditions, anyone experiencing sudden vision loss should seek immediate medical care for prompt evaluation.
How Is Retinal Vein Occlusion Managed?
Management of retinal vein occlusion typically addresses both the eye and any underlying systemic risk factors. Anti-VEGF injections are commonly used when macular edema develops as a result of the occlusion, aiming to reduce swelling and stabilize or improve vision. Laser photocoagulation may also play a role in select cases, particularly for complications such as abnormal new blood vessel growth (neovascularization) that can develop in more severe or long-standing occlusions. Alongside eye-directed treatment, managing blood pressure, cholesterol, and blood sugar is typically emphasized, since these factors relate directly to the underlying vascular process and to the patient's broader cardiovascular risk.
What Is the Long-Term Outlook?
Visual outcomes after retinal vein occlusion vary considerably and depend on the type of occlusion, whether the macula was involved, and how promptly complications such as edema or neovascularization are identified and treated. Some patients recover a meaningful degree of vision with treatment, while others experience more lasting visual impairment, particularly with central retinal vein occlusion or when treatment is delayed. A qualified ophthalmologist determines the appropriate monitoring schedule and treatment plan based on the specific type and severity of occlusion, since no single outcome can be predicted for every patient.
Does having retinal vein occlusion mean a person is at risk for other health problems?
Because retinal vein occlusion shares risk factors with cardiovascular disease, such as high blood pressure and high cholesterol, a diagnosis often prompts a broader health evaluation. Physicians commonly recommend follow-up with a primary care provider to assess and manage these related risk factors.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.